Literature DB >> 21075023

Elevated CSF-lactate is a reliable marker of mitochondrial disorders in children even after brief seizures.

Martin Magner1, Karol Szentiványi, Ivana Svandová, Pavel Ješina, Markéta Tesařová, Tomáš Honzík, Jiří Zeman.   

Abstract

BACKGROUND: Increased lactate is an important biochemical marker in diagnosis of children with suspicion of mitochondrial disorders. A diagnostic dilemma may originate if analyses are performed after seizures, when the increased lactate levels may be considered to result from the seizures. To address this problem, we ascertained the diagnostic value of lactate and alanine in blood (B) and cerebrospinal fluid (CSF) in children with mitochondrial disorders (n = 24), epilepsy (n = 32), psychomotor retardation (n = 23), meningitis (n = 12) and meningism (n = 16).
METHODS: Lactate concentration was measured using a spectrophotometric method. Amino acids in serum and CSF were analyzed by ion exchange chromatography with ninhydrin detection.
RESULTS: Average blood and CSF-lactate levels were significantly higher in children with mitochondrial disorders (3.87 ± 0.48 and 4.43 ± 0.55 mmol/l) and meningitis (2.77 ± 0.45 and 8.58 ± 1.08 mmol/l) than in children with epilepsy (1.72 ± 0.13 and 1.62 ± 0.04 mmol/l), psychomotor retardation (1.79 ± 1.40 and 1.68 ± 0.06 mmol/l) or meningism (1.70 ± 0.13 and 1.64 ± 0.07 mmol/l). Blood and CSF-alanine levels were also higher in children with mitochondrial disorders (558 ± 44 and 51 ± 8 μmol/l) than in children with epilepsy (327 ± 23 and 27 ± 3 μmol/l) or psychomotor retardation (323 ± 27 and 26 ± 3 μmol/l). The CSF-lactate levels of children with epilepsy were similar whether the samples were obtained 3 ± 0.6 h after an attack of brief seizures or from children without history of recent seizures.
CONCLUSION: Elevated cerebrospinal fluid lactate level is a reliable marker pointing to mitochondrial origin of disease, even in children who have recently suffered short-lasting seizures. Some children with mitochondrial disorders manifest only mild or intermittent elevation of lactate levels.
Copyright © 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075023     DOI: 10.1016/j.ejpn.2010.10.001

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  10 in total

1.  Response.

Authors:  Michael J Griffiths; Fiona McGill; Tom Solomon
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

2.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.

Authors:  Tomas Honzik; Marketa Tesarova; Martin Magner; Johannes Mayr; Pavel Jesina; Katerina Vesela; Laszlo Wenchich; Karol Szentivanyi; Hana Hansikova; Wolfgang Sperl; Jiri Zeman
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

Review 3.  The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders.

Authors:  Nadia Turton; Neve Cufflin; Mollie Dewsbury; Olivia Fitzpatrick; Rahida Islam; Lowidka Linares Watler; Cara McPartland; Sophie Whitelaw; Caitlin Connor; Charlotte Morris; Jason Fang; Ollie Gartland; Liv Holt; Iain P Hargreaves
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

Review 4.  Progress in Diagnosing Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes.

Authors:  Ying-Xin Wang; Wei-Dong Le
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

5.  Diagnostic value of MRS-quantified brain tissue lactate level in identifying children with mitochondrial disorders.

Authors:  Roelineke J Lunsing; Kim Strating; Tom J de Koning; Paul E Sijens
Journal:  Eur Radiol       Date:  2016-06-07       Impact factor: 5.315

6.  Cerebrospinal fluid lactate concentrations in dogs with seizure disorders.

Authors:  Christopher L Mariani; Carolyn J Nye; Laura Ruterbories; Debra A Tokarz; Lauren Green; Jeanie Lau; Natalia Zidan; Peter J Early; Karen R Muñana; Natasha J Olby; Chun-Sheng Lee; Julien Guevar
Journal:  J Vet Intern Med       Date:  2020-11-02       Impact factor: 3.333

7.  Neurofilament light is a novel biomarker for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.

Authors:  Yong-Sheng Zheng; Chong Sun; Rong Wang; Ne Chen; Su-Shan Luo; Jian-Ying Xi; Jia-Hong Lu; Chong-Bo Zhao; Yu-Xin Li; Lei Zhou; Jie Lin
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

8.  Correlation of Serum Biomarkers and Magnetic Resonance Spectroscopy in Monitoring Disease Progression in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Due to mtDNA A3243G Mutation.

Authors:  Ha Neul Lee; Choon-Sik Yoon; Young-Mock Lee
Journal:  Front Neurol       Date:  2018-07-27       Impact factor: 4.003

9.  Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders.

Authors:  Christopher L Mariani; Carolyn J Nye; Debra A Tokarz; Lauren Green; Jeanie Lau; Natalia Zidan; Peter J Early; Julien Guevar; Karen R Muñana; Natasha J Olby; Sarita Miles
Journal:  J Vet Intern Med       Date:  2019-09-24       Impact factor: 3.333

Review 10.  Mitochondrial genetics.

Authors:  Patrick Francis Chinnery; Gavin Hudson
Journal:  Br Med Bull       Date:  2013-05-22       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.